Nishio H, Nezasa K, Nakata Y
Department of Pharmacology, Hiroshima University, School of Medicine, Japan.
Eur J Pharmacol. 1995 Jan 16;288(2):149-55. doi: 10.1016/0922-4106(95)90189-2.
It is generally accepted that intracellular Ca2+ is a key substance in the intracellular signal transducing mechanism of platelets. We investigated the possibility that extracellular and/or intracellular Ca2+ might regulate the transport activity of serotonin (5-HT) into platelets. We found that extracellular Ca2+ chelation with EGTA caused inhibition of 5HT uptake activity, which was recovered by extracellulary applied excess Ca2+. Intracellular Ca2+ chelation with acetoxymethyl bis(O-aminophenoxy)ethane-N,N,N'-tetraacetate (BAPTA-AM) did not, however, have any inhibitory effect on 5HT uptake activity in the presence of extracellular Ca2+. In the absence of extracellular Ca2+, BAPTA-AM significantly inhibited 5-HT uptake. The restorative effect of Ca2+ on 5-HT transport into EGTA-treated platelets was mimicked by Ba2+, but not by Sr2+. It was antagonised by inorganic Ca2+ channel antagonist including Ni2+, La3+ and Gd3+, but not by organic Ca2+ channel blockers including verapamil, nifedipine, diltiazem, omega-conotoxin GVIA and omega-agatoxin IVA. Furthermore, 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester hydrochloride (TMB-8), an intracellular Ca2+ antagonist, was found to inhibit the restorative effect of Ca2+. These results have led to the suggestion that depletion of intracellular Ca2+ pool(s) by EGTA might result in a reduction of 5-HT uptake activity. Thus, the intracellular Ca2+ pool(s) susceptible to EGTA might have a regulatory role in maintaining 5-HT transport into blood platelets.
一般认为,细胞内钙离子是血小板细胞内信号转导机制中的关键物质。我们研究了细胞外和/或细胞内钙离子可能调节血清素(5-羟色胺,5-HT)转运到血小板中的活性这一可能性。我们发现,用乙二醇双四乙酸(EGTA)螯合细胞外钙离子会导致5-HT摄取活性受到抑制,而通过细胞外施加过量钙离子可使其恢复。然而,在细胞外存在钙离子的情况下,用乙酰氧基甲基双(O-氨基苯氧基)乙烷-N,N,N'-四乙酸(BAPTA-AM)螯合细胞内钙离子对5-HT摄取活性没有任何抑制作用。在没有细胞外钙离子的情况下,BAPTA-AM会显著抑制5-HT摄取。钙离子对5-HT转运到经EGTA处理的血小板中的恢复作用可被钡离子模拟,但不能被锶离子模拟。它会被包括镍离子、镧离子和钆离子在内的无机钙离子通道拮抗剂拮抗,但不会被包括维拉帕米、硝苯地平、地尔硫䓬、ω-芋螺毒素GVIA和ω-阿加毒素IVA在内的有机钙离子通道阻滞剂拮抗。此外,发现细胞内钙离子拮抗剂盐酸3,4,5-三甲氧基苯甲酸8-(二乙氨基)辛酯(TMB-8)会抑制钙离子的恢复作用。这些结果表明,EGTA耗尽细胞内钙离子池可能导致5-HT摄取活性降低。因此,易受EGTA影响的细胞内钙离子池可能在维持5-HT转运到血小板中起调节作用。